Peptides are short amino acid chains. In telehealth the commonly prescribed examples include sermorelin and NAD+ formulations, dispensed through licensed compounding pharmacies.
The category attracts more regulatory scrutiny than any other in direct-to-consumer telehealth, and the exposure usually comes from marketing claims rather than from the clinical workflow.
A defensible peptide program offers only legally prescribable compounds, requires genuine provider review on every order with no auto-approve path, and keeps storefront claims substantiated.
This is the category where an ad account is most likely to be lost and where FTC claim substantiation matters most. Catalog discipline and claims review are the controls that keep a peptide brand operating.
Peptide therapy, in practice
Legally prescribable compounds, prescribed by a licensed provider for an appropriate patient and dispensed by a licensed compounding pharmacy, yes. Research-use-only positioning is a different activity and PharmaBro does not support it.